Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nano-HAP and Potassium Nitrate for Dentin Hypersensitivity in MIH
NCT07056855Not yet recruiting
- Sponsor
- Cairo University
- Start
- Jul 2025
- Primary completion
- Jul 2025
- Modality
- Nanoparticles, Device-based Delivery, DNA Intercalators/Alkylators
01
Overview
Randomised trial of nanohydroxyapatite and potassium nitrate in dentin hypersensitivity (DH) (3 arms), sponsored by Cairo University. Primary endpoint: Dentin Hypersensitivity at 4 weeks. Planned start Jul 2025; status: not yet recruiting.
02
Drugs
nanohydroxyapatitepotassium nitrate
03
Conditions
dentin hypersensitivity (DH)
Beyond the preview
Go deeper on NCT07056855.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07056855.